Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
Recruiting
Observational Study
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 38 (estimated)
- Sponsor
- Masonic Cancer Center, University of Minnesota · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This clinical trial evaluates the use of a tool kit, Stress, Affect, Language and Speech Analysis (SALSA), for early identification of cognitive side effects of immunotherapy compared to the standard of care assessment.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* \* ≥ 18 years of age at initiation of therapy
* Planning to undergo inpatient CAR-T therapy for primary malignancy
* Fluent in English (written or spoken)
Exclusion Criteria:
* \* Subjects with speech or hearing impediment that would make them unable to be assessed with…
Contacts
No contact information available.